Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Early Detection of Diastolic Dysfunction and the Role of Lifestyle Measures in Its Treatment

This study has been completed.
Sponsor:
Information provided by:
University of Missouri-Columbia
ClinicalTrials.gov Identifier:
NCT00998114
First received: October 19, 2009
Last updated: June 15, 2011
Last verified: June 2011

October 19, 2009
June 15, 2011
June 2008
May 2010   (final data collection date for primary outcome measure)
Exercise echo Doppler will be done at baseline and after completion of 6 months of an exercise program [ Time Frame: Beginning of study participation and after 6 months of study participation ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00998114 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Early Detection of Diastolic Dysfunction and the Role of Lifestyle Measures in Its Treatment
Early Detection of Diastolic Dysfunction and the Role of Lifestyle Measures in Its Treatment

The project aims to investigate the effect of a regular exercise for 6 months on diastolic parameters in patients who present with shortness of breath and who have evidence of early diastolic dysfunction on echocardiography. Patients will be enrolled from the VA General Medicine and Cardiology Clinics, and will be screened for diastolic dysfunction. Once enrolled, they will be on an exercise regimen that involves aerobic exercise for 30-45 minutes five times a week at home. The participants will have an initial supervised exercise session with the VA Cardiac Rehabilitation team, and will have either every other week or monthly supervised sessions at the VA Cardiac Rehabilitation Center to monitor their progress. Clinical, biometric, laboratory and echocardiographic parameters will be obtained before and after the 6 month period.

Introduction:

Diastolic dysfunction (DD) accounts for >50% of all heart failure (DHF) hospitalizations and this number is increasing with age, obesity and diabetes.

There are no proven treatments for DHF apart from blood pressure control.

Aim:

If diagnosed early, is this reversible with lifestyle changes; namely, aerobic exercise and weight reduction?

Methods:

We will screen veterans presenting to the medicine, cardiology and pulmonary services with dyspnea. We will perform echocardiography with Doppler which non-invasively measures cardiac filling and diastolic dysfunction. Treadmill exercise echo will be performed to quantify DD.

Bruce treadmill protocol description/ procedure: Exercise is performed on a treadmill. The test starts at 2.74 km/hr (1.7 mph) and at a gradient (or incline) of 10%. At three minute intervals the incline of the treadmill increases by 2%, and the speed increases as shown in the table below.

Stage Speed (mph) Gradient:

  1. 1.7 10
  2. 2.5 12
  3. 3.4 14
  4. 4.2 16
  5. 5.0 18
  6. 5.5 20
  7. 6.0 22
  8. 6.5 24
  9. 7.0 26
  10. 7.5 28

Subject exercise study:

For physical exercise to have a beneficial effect on cardiac function, we suggest the following:

  • Type of Exercise
  • Walking - outdoors or treadmill
  • Running or jogging
  • Cycling - outdoors or stationary

Duration of Exercise:

Initial 2-3 minute gradual warm-up period. Roughly 30 minutes of continuous exercise 5 times a week.

Finally a few minutes of gradual cool-down before terminating exercise.

Intensity of Exercise:

Target exercise at a "moderately significant exertion".

We will demonstrate what is adequate in the beginning and periodically throughout the 6 months of the study.

"Maximum age predicted heart rate (MPHR)" is calculated as 220 minus subject's age. Then we would like to sustain roughly about 70 to 85% of MPHR for 25-30 minutes.

"Successful" Exerciser: Subjects who are able to adhere to the required intensity and duration of exercise for the majority (about 75% or more) of the time; averaging 150 minutes/ week on self reporting.

Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Prevention
Diastolic Dysfunction
Behavioral: Exercise
Aerobic exercise for 30-45 minutes five times a week for six months
Other Name: Diastolic Dysfunction
Experimental: Exercise and diastolic dysfunction
Intervention: Behavioral: Exercise
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
150
May 2011
May 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with dyspnea/shortness of breath
  • Age 40-65 years of age
  • Sedentary lifestyle (<150 minutes of exercise/week)
  • Echocardiographic evidence of early diastolic dysfunction: mitral E/A <0.9, OR resting E/E' between 8-15 cm/s, OR post-exercise E/E' >13 cm/s.

Exclusion criteria:

  • Age <40 years or >65 years
  • Coronary Artery Disease by angiography or evidence of ischemia on a stress test
  • Systolic Dysfunction (LV Ejection fraction <50%)
  • Congestive Heart Failure Functional Class III or IV
  • Moderate to severe COPD (FEV <80% predicted)
  • Moderate to severe valvular heart disease, except tricuspid regurgitation
  • Inability to get heart rate >/= 85% of maximum predicted heart rate
  • Uncontrolled hypertension (systolic BP>140mmHg, diastolic BP>90mmHg) despite medical therapy
  • On echocardiogram, RV systolic pressure >60mmHg that suggests severe pulmonary hypertension
  • On echocardiogram, left atrial size> 6.5 cm or left atrial volume > 35 ml/BSA
Both
40 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00998114
1115737
No
Anand Chockalingam, MD, Assistant Clinical Professor of Medicine, University of Missouri
University of Missouri-Columbia
Not Provided
Principal Investigator: Anand Chockalingam, MD University of Missouri/Harry S Truman VA Hospital
University of Missouri-Columbia
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP